Bumi Serpong Damai Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bumi Serpong Damai Tbk trades at Rp585 (market cap 12.6T, 5.48M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Bumi Serpong Damai Tbk is far larger — about 76.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bumi Serpong Damai Tbk is more actively traded (5.48M versus 187.4K). Which is the better fit depends on your goals.
| BSDE | OBAT | |
|---|---|---|
Market Cap | 12.6T | 164.65B |
Volume | 5.48M | 187.4K |
Lot | 54.77K | 1.87K |
Turnover | 3.23B | 44.35M |
Average Price | 589.34 | 236.67 |
Value | 3.23B | 44.35M |
Indicative Equilibrium Price | 585 | 242 |
Indicative Equilibrium Volume | 999 | 500 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bumi Serpong Damai Tbk (the company) was established on January 16, 1984 based on the Notarial Deed No. 50 of Benny Kristianto, S.H., a public notary in Jakarta. The Company’s articles of association has been amended several times, most recently by notarial deed No. 01 of Tarwiyah, S.H., dated Jan 25, 2008, concerning company's public offering.
Read more on BSDE →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →